Roche reports phase 3 breast cancer victory for oral SERD
Roche has reported a phase 3 win for its oral selective estrogen receptor degrader (SERD), bouncing back from an…
Roche heads to FDA as phase 3 eye disease trials yield mixed data
Roche is forging ahead with plans to seek approval for an eye disease drug candidate despite missing the primary…
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor
Roche has reported wins for its BTK inhibitor fenebrutinib in a pair of phase 3 studies across two multiple…
Roche unveils data behind BTK inhibitor’s phase 3 MS win
Roche has shared the numbers behind its phase 3 win in primary progressive multiple sclerosis (PPMS), linking its BTK…